Your browser doesn't support javascript.
loading
Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma.
Carmell, Natasha; Rominiyi, Ola; Myers, Katie N; McGarrity-Cottrell, Connor; Vanderlinden, Aurelie; Lad, Nikita; Perroux-David, Eva; El-Khamisy, Sherif F; Fernando, Malee; Finegan, Katherine G; Brown, Stephen; Collis, Spencer J.
Affiliation
  • Carmell N; Weston Park Cancer Centre, Department of Oncology & Metabolism, The University of Sheffield Medical School, Sheffield S10 2SJ, UK.
  • Rominiyi O; Weston Park Cancer Centre, Department of Oncology & Metabolism, The University of Sheffield Medical School, Sheffield S10 2SJ, UK.
  • Myers KN; Department of Neurosurgery, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S10 2JF, UK.
  • McGarrity-Cottrell C; Weston Park Cancer Centre, Department of Oncology & Metabolism, The University of Sheffield Medical School, Sheffield S10 2SJ, UK.
  • Vanderlinden A; Weston Park Cancer Centre, Department of Oncology & Metabolism, The University of Sheffield Medical School, Sheffield S10 2SJ, UK.
  • Lad N; Weston Park Cancer Centre, Department of Oncology & Metabolism, The University of Sheffield Medical School, Sheffield S10 2SJ, UK.
  • Perroux-David E; Weston Park Cancer Centre, Department of Oncology & Metabolism, The University of Sheffield Medical School, Sheffield S10 2SJ, UK.
  • El-Khamisy SF; Weston Park Cancer Centre, Department of Oncology & Metabolism, The University of Sheffield Medical School, Sheffield S10 2SJ, UK.
  • Fernando M; Sheffield Institute for Nucleic Acids (SInFoNiA) and the Healthy Lifespan Institute, University of Sheffield, Sheffield S10 2TN, UK.
  • Finegan KG; Institute of Cancer Therapeutics, University of Bradford, Bradford BD7 1DP, UK.
  • Brown S; Department of Histopathology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S10 2TN, UK.
  • Collis SJ; Faculty of Biology Medicine and Health, University of Manchester, Manchester M13 9PL, UK.
Cancers (Basel) ; 13(5)2021 Feb 24.
Article in En | MEDLINE | ID: mdl-33668183

Full text: 1 Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2021 Type: Article Affiliation country: United kingdom

Full text: 1 Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2021 Type: Article Affiliation country: United kingdom